Podcasts about Medicine

ECMO is the topic of this week's episode of Pediheart. We speak with Assistant Professor of Pediatrics and cardiac critical care specialist at Northwell Health, Dr. Ivana Capin about a recent ELSO database study she conducted to assess outcomes in single ventricle patients who were treated with ECMO prior to single ventricle palliation. What factors were associated with worse overall outcomes? Can this therapy be used to stabilize the HLHS patient with an intact atrial septum? Why have outcomes for this high risk patient group not appreciably improved in the recent decade? How can these data improve prognostic clarity when speaking with families in this difficult situation.Also joining us briefly is Associate Professor of Pediatrics at the Icahn School of Medicine at Mount Sinai, Dr. Scott Aydin to discuss his co-author and mentor, Dr. George Ofori-Amanfo as we approach the 4th anniversary of his untimely and tragic passing. DOI: 10.1017/S1047951125001386

In this episode, we sit down with Kristin Burton, MPAS, PA-C—a pulmonary and critical care physician assistant and founder of Millionaires in Medicine. Kristin shares her incredible journey from paying off over $160,000 in student loans in just 16 months to reaching millionaire status by age 31. She explains how financial literacy transformed her life and why it's essential for medical professionals to prioritize it.We also dive into Kristin's career path, from clinical work to adjunct faculty roles, expert witness gigs, and entrepreneurship, offering practical tips on time management, networking, and building wealth without sacrificing your medical career. Plus, Kristin gives us a look at her company's mission to help thousands of clinicians achieve financial freedom.Learn more and access free resources at millionairesinmedicine.com.

In today's episode, we had the pleasure of speaking with Catherine Shu, MD, about the use of tepotinib (Tepmetko) in patients with non–small cell lung cancer harboring MET exon 14 skipping mutations. Dr Shu is the Price Family Associate Professor of Medicine and the clinical director of the Thoracic Medical Oncology Service at the Columbia University Herbert Irving Comprehensive Cancer Center in New York, New York.  In our exclusive interview, Dr Shu discussed updated data from the phase 2 VISION trial (NCT02864992) that investigated tepotinib in this population, the notable efficacy of this agent in treatment-naive patients, and considerations for managing and mitigating the adverse effects associated with this therapy. 

In this episode, Guy talked with Dr. Nisha Manek. She challenges conventional understandings of consciousness and delves into the intersection of science and spirituality. Emphasizing that consciousness is not a product of the brain, Nisha discussed the latent capacities of human beings and the need to elevate our levels of conscious awareness. Through her experiences as a medical doctor and her studies with physicist William Tiller, she explored the potential of intention to affect physical reality, the limitations of modern medicine, and the importance of inner work. Nisha also shared practical advice on meditation and the transformative power of silence. About Dr. Nisha: Nisha Manek is an internally recognized leader in the field of integrative medicine. Nisha's humble background from Kenya propelled her to transcend limitations: gender, ethnicity, and financial status. From Case Western Reserve University in Cleveland, Ohio, where she graduated Summa cum laude, to the University of Glasgow School of Medicine in Scotland, Nisha's uncommon tenacity has driven her to ask difficult questions and pursue answers beyond traditional medical paradigms.  Nisha began her career in rheumatology at the Mayo Clinic in Rochester, Minnesota. Recognized as Teacher of the Year in the School of Medicine, she brings storytelling as a core skill to bedside medical teaching and on the plenary stage.  But she didn't stop there. Nisha partnered with one of the world's most innovative physicists, Emeritus Professor William A. Tiller of Stanford University, and pushed the boundaries of what is possible in medicine. She is the preeminent doctor of information medicine, which intersects consciousness, biofield science, and rheumatology to improve human health.  She has authored a one-of-a-kind book, Bridging Science and Spirit, which closes the gap between two seemingly separate areas of knowledge. She is a fellow of the American College of Physicians and a fellow of the Royal College of Physicians of the United Kingdom. Key Points Discussed:  (00:00) - The Hidden Science of Consciousness They Never Taught Us! (00:41) - Welcome to the Podcast (01:11) - The Seeker of Truth (01:43) - Straying from the Truth (02:57) - The Invisible Essence of Consciousness (04:46) - Bridging Science and Spirit (07:25) - The Role of Intention in Medicine (08:07) - The Human Behind the Technology (09:42) - The Power of Consciousness and Intention (12:59) - Meeting William Tiller (22:59) - The Experiment with Water (26:40) - The Unique Feel of Different Spaces (27:13) - The Sacredness of Tiller's Lab (27:49) - Bridging Science and Spirit (29:11) - The Power of Intention and Energy (32:11) - The Potential of Human Consciousness (39:51) - Daily Practices for Consciousness (49:05) - Reflections and Personal Journey (51:09) - Final Thoughts and Book Information How to Contact Dr. Nisha Manek:www.nishamanekmd.com   About me:My Instagram: www.instagram.com/guyhlawrence/?hl=en Guy's websites:www.guylawrence.com.au www.liveinflow.co''

In this episode of The Public Health Joy Podcast, Dr. Joyee sits down with Silas Buchanan, founder and CEO of Our Healthy Community, a social impact consulting firm in partnership with Morehouse School of Medicine. Their mission: to close the distance between faith-based organizations, community-based organizations, and healthcare stakeholders.Together, Dr. Joyee and Silas explore what it truly means to bridge the gaps between communities and the health systems meant to serve them. Silas shares why a web-based ecosystem is essential for empowering underserved communities through technology, ownership, and collaboration. He also highlights the influence of faith-based institutions in health messaging and the urgent need for community voices in designing digital health tools. This conversation shines a light on equity in research and the transformative power of community engagement in achieving real health equity.Key Points From This Episode:The goal is to bridge gaps between community organizations and healthcare stakeholders. [02:46]Technology can empower communities and improve health outcomes.[08:57]Community input is essential in the design of health technologies. [12:00]Ownership of digital spaces is crucial for community control. [14:53]Equity in research and development is necessary for effective solutions. [20:57]Faith-based organizations play a vital role in health messaging. [23:52]Options are better than money; providing more choices leads to empowerment. [29:54]If you enjoyed this episode, please subscribe, rate and, leave a review! For more transcripts, show notes,and more visit: https://joyeewashington.com/public-health-joy-season-4/ 

Join Dr. Bahar Force, Endocrinologist, Medical Director of the Pituitary Center, and Associate Program Director of the Endocrinology Fellowship Program at Baylor College of Medicine, as she speaks with leading experts Dr. James Findling, Clinical Professor of Endocrinology at the Medical College of Wisconsin, and Dr. Ty Carroll, Visiting Professor of Endocrinology and Chief of the Division of Endocrinology, Diabetes and Metabolism at the University of Wisconsin Madison, for a clinician-focused conversation on non-neoplastic hypercortisolism. Together, they discuss how common conditions can lead to cortisol elevations that resemble Cushing syndrome, the clinical patterns that raise concern for neoplastic hypercortisolism, and the growing role of the Desmopressin Stimulation Test in helping distinguish between the two. The episode also highlights emerging research, including insights from the Catalyst study and the potential role of cortisol-directed therapy. 

This is part 1 of a 2-part series exploring the future of farming seafood in the Gulf. Americans eat a lot of farmed seafood — but the vast majority of it comes from overseas. We just don't farm fish on a big scale in U.S. waters. Now that might start to change. There are proposals to build massive fish farms in U.S. federal waters. And guess which coast is likely to be the first home for these new farms? You guessed it, the Gulf.So is this a miracle cure or a looming ecological disaster?-----This series is produced in partnership with the Food and Environment Reporting Network. This episode was hosted by Carlyle Calhoun and Boyce Upholt. Boyce also reported this episode. Editing by Jack Rodolico. Carlyle Calhoun is the executive producer. The episode was fact-checked by Garrett Hazelwood. Our theme music is by Jon Batiste, and our sound designer is Emily Jankowski.Voices featured at the top of the episode in order of appearance: Melvin Jackman in Newfoundland, Fay Orfanidou in Greece, Nick Underdown in Scotland, and Leticia Caro and Claudio Carocca in Chile.Sea Change is a WWNO and WRKF production. We are part of the NPR Podcast Network and distributed by PRX. Sea Change is made possible with major support from the Gulf Research Program of the National Academy of Sciences, Engineering, and Medicine. Sea Change is also supported by the Water Collaborative of Greater New Orleans. WWNO's Coastal Desk is supported by the Walton Family Foundation, the Meraux Foundation, and the Greater New Orleans Foundation.

Here are today's topics: Kandi Burruss and Todd Tucker are divorcing! Jen Shah is getting out of prison in a week! RHOBH Season 15 premiere recapMarried to Medicine season 12 premiere recap! I hope you enjoyed today's show!

What happens when a company decides to put real food at the center of employee wellness? In this powerful episode, Rip sits down with the team at Central Garden & Pet, a 7,000-employee organization that has taken a radically forward-thinking approach to improving the health of its people. Their partnership with PLANTSTRONG by Metabite has produced clinical-level outcomes — without drugs, deprivation, or pressure to “go vegan.”Rip is joined by Dawn Hutchins, Central's Director of Plant-Based Nutrition, who shares how the program was born, what she learned from a year of research and focus groups, and why this isn't a “check-the-box” wellness initiative. She breaks down how the program works — from smart devices and at-home blood testing to weekly coaching, short video lessons, cooking demos, AI support, and a thriving alumni community.You'll also hear from two inspiring graduates, Vicky and Dan, who reveal what motivated them to join, the fears they had going in, and the surprising shifts they experienced as they added more plants to their plates. Their stories underscore a simple truth: when people feel supported, connected, and empowered with real tools, transformation follows.If you're a business leader, HR professional, or anyone curious about the future of Food as Medicine, this episode offers a clear and inspiring blueprint for what's possible when nutrition becomes the foundation of workplace wellness.Plant Strong by Metabite Program: https://liveplantstrong.com/corporate-wellness-solution/ Episode WebpageWatch the Episode on YouTubeLearn More About our 2026 Live PLANTSTRONG Events: https://plantstrong.com/pages/events Let Us Help Your PLANTSTRONG JourneyTake the Free 7-Day Challenge: https://liveplantstrong.com/free-7-day-challenge/ Learn More About Our Corporate Wellness Program: https://liveplantstrong.com/corporate-wellness/ COMPLEMENT: Use code PLANTSTRONG for 30% off at https://lovecomplement.com/pages/plantstrong-special-offer Follow PLANTSTRONG and Rip Esselstynhttps://plantstrongfoods.com/ https://www.facebook.com/GoPlantstrong https://www.instagram.com/goplantstrong/https://www.instagram.com/ripesselstyn/ Follow the PLANTSTRONG Podcast and Give the Show a 5-star RatingApple PodcastsSpotify

Do you feel like you get crazy histamine intolerance symptoms as your body reacts to everything — certain foods, smells, stress, or even the weather? Symptoms such as itchy skin, rashes, dermatographia, angioedema, bloating, or headaches that seem to appear out of nowhere are often linked to histamine intolerance.But before you blame your diet and dive headfirst into a low-histamine diet, know that food isn't likely to blame. After working with over 1,000 clients, I can tell you that there are deeper, more pressing issues that drive urticaria and chronic hives.Let's dive into why you probably don't have histamine intolerance (despite having all the symptoms), how histamine intolerance differs from MCAS, and what's really triggering these crazy histamine reactions. From mold exposure to liver detox issues and hormone imbalances, we explore how these hidden factors can lead to ongoing inflammation and itchy skin that just won't quit.⭐️Mentioned in This Episode:- FREE Root Cause Finder Guide - https://www.skinterrupt.com/rootcauseguide-pod - See all the references

Have you ever wondered what would happen if you stripped away every distraction —  your screens, your routines, and even your ability to see? What hidden thoughts would rise to the surface? What suppressed emotions would finally have room to move? And what would catch up to you that you have been running from, for potentially years. In this episode, I sit down with Scott Berman, the founder of Sky Cave Retreats, which is the first darkness retreat center in the United States. Scott has spent more than 70 days in total darkness and has guided over 600 people through this profound inner journey. And after doing a darkness retreat myself, I finally understand why SkyCaves is booked out for 3 years and has a 3000-person waitlist. Darkness itself is a threat to the nervous system. And Scott lets everyone know who signs up that their system will probably not react the way they anticipate. He shares that the only thing one needs to bring is HONESTY, and what happens to those who don't.  I share my experience during 4 nights and 3 days in pitch blackness and the profound breakthroughs that occurred when I stopped running from, escaping, and numbing my deepest, rawest feelings. This episode is for anyone curious about nervous system healing, the addiction to the stories that hijack our minds, or what becomes possible when you meet yourself with honesty, zero distractions, and the primordial pressure of the dark. Scott is a beautiful human who leaves us with this question before we enter the cave and turn off the lights: “What would nurture do in this moment?” The answer is usually what we should follow to create the safety in our system we are all searching for.    This episode is for all those who are afraid of the dark and those who are afraid of the parts of themselves that may be trapped in the darkest recesses of their subconscious. Luckily, Scott has the compassion, calm, and skills to hold our hand through it all.  Key Moments You'll Love ✨:

Dr. Dillon Caswell is a Board Certified Sports Specialist Doctor of Physical Therapy, Human Performance Coach, and Top-Selling Author, who utilizes hope and modern neuroscience to replace the ‘nopes' we face and empower desiring lifelong athletes to reclaim their birthright of healthy and athletic. With the strategy of Hope, Dr. Dillon Caswell has guided a range of beginners up to world-class athletes including former NFL players, Top-level CrossFitters, D1-D3 College Athletes, Military Special-Ops, World-Touring Performing Artists, World-Ranked Track Athletes, World Ranked Strongmen and Powerlifters, and everyday people - regardless of age or experience.

Send me a question or story!Solar dermatitis (actinic keratosis) is skin damage from prolonged UV exposure, affecting both dogs and cats, particularly those with light-colored or thin coats. So, pets that have white fur and live in high UV exposure areas (like the southern US) are predisposed. Symptoms include redness, scaling, hair loss, and thickened, crusty skin. Commonly affected areas include the nose, ears, abdomen, and inner thighs. This condition can lead to more severe issues, including pre-cancerous lesions and aggressive skin cancer like squamous cell carcinoma. We will discuss ways to identify this disease and treatment options such as CO2 laser ablation, etc.00:00 – Intro04:06 – Nasal Solar Dermatitis06:32 – Classic Canine Solar Dermatitis08:15 – Treatment Options for Solar Dermatitis16:52 – Outro

Nutritional strategies for treating Barrett's EsophagusHow can my uncle mitigate the side effects of his Merkel cell carcinoma therapy?How long can I take strontium?Is beet root powder beneficial for nitric oxide production?

The best water filter?Even more on gadoliniumVagus nerve therapy benefitsWith so many benefits of drinking coffee, should I drink more of it instead of tea?Any update on Barrett's Esophagus?

HOW HOSPITALS ARE DRIVING UP HEALTHCARE COSTS The thing that makes health insurance so expensive is the COST of the healthcare being delivered, and as we try to fix health insurance we can't do so without acknowledging what is driving those costs. One bit thing is hospital consolidation. Hospitals are buying up private practices, surgical centers and more and then leveraging their monopoly powers to charge more to insurance companies, who then charge more to insurers. I've got Peter Pitts, former Associate FDA Commissioner and President of the Center for Medicine in the Public Interest on at 1pm to talk about it. He recently testified before Congress and in part had this to say:“Healthcare in the United States is in a crisis of affordability and accountability. In 2023, Americans spent more than $1.5 trillion at hospitals—nearly one-third of total health expenditures. Hospital systems, especially nonprofit institutions, are the primary driver of healthcare cost inflation and systemic inefficiency.”If we want to lower healthcare costs, we have to fix this broken system. Peter also has a book out about the process of creative destruction and how to leverage it and you can buy it here.

Mary Emfinger, a third-year veterinary student at NC State College of Veterinary Medicine, joins us on the show this week for an inspiring episode. She shares how she balances vet school, motherhood, serving as a SAVMA senior delegate, and launching her own compression sock business, Bright Alert Responsive. She reflects on learning patience, following ideas that won't let go, embracing work-life integration, and how being a second-career student highlights the strong teamwork and collaboration in veterinary medicine that she hopes to carry into her future career. We can't wait to share her story with you!Thank you to our podcast partner, the AVMA Career Center. Are you a veterinary professional looking for a position change or even a complete change of scenery? The AVMA Career Center is THE place for all veterinary professionals to find the next step in their career journey. Learn more and explore career resources at https://www.avma.org/careersRemember, we want to hear from you! Please be sure to subscribe to our feed on Apple Podcasts and leave us a rating and review. You can also contact us at MVLpodcast@avma.orgFollow us on social media @AVMAVets #MyVetLife #MVLPodcast

In this enlightening episode of Brown Women Health, psychiatrist Dr. Rathisha Pathmathasan, DO joins us to explore the importance of mindfulness, mental wellness, and breaking cultural stigma in South Asian communities. We dive into her journey into psychiatry, the pressures of med school as a South Asian American, and the common signs of anxiety, depression, trauma, and other mental health concerns.Dr. Pathmathasan shares practical steps listeners can take before seeking professional help, how to communicate mental health struggles to older generations, and why many people feel intimidated by psychiatry. We also address topics like pill shaming, myths surrounding psychiatric care, and the role of holistic practices—including her own science-based Mindful Planner.Join us as we unpack what mental wellness looks like for students, women, and people of color, and how mindfulness can support healing, resilience, and everyday balance.Anchored by: Esha AggarwalProduced by: Esha Aggarwal & Mrinal Gokhale

Dr. Angela Sturm joins Dorothy to share how her work as a facial plastic surgeon centers on empowering women and building self-confidence. With a blend of surgical skill and empathy, Dr. Sturm guides patients through life-changing procedures, always focusing on the person behind the procedure. Her leadership in medicine and advocacy for cancer survivors remind us all that self-care is a powerful statement of strength. Learn more about Dr. Sturm HERE. Subscribe to Beauty Unveiled on Apple, Spotify, and YouTube. Support The Rose HERE. Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts. Key Questions Answered 1. What is facial plastic surgery and what does it encompass?2. What type of conversations take place during consultations about cosmetic procedures?3. Why is it important for patients seeking facial plastic surgery to have support from family or friends?4. How does Dr. Angela Sturm prepare a patient’s supporters for the process of surgery and recovery?5. Has Dr. Angela Sturm ever turned down a patient, and why?6. Why is feeling better about yourself (self-confidence) important after cosmetic procedures?7. Is there still stigma attached to plastic surgery, and has it changed over time?8. What hair restoration options are available, especially for women who’ve experienced hair loss after chemotherapy? Timestamped Overview 00:00 Facial Plastics and Self-Identity 04:57 Collaborative Consultation for Best Outcomes 08:16 Discovering Passion for Surgery 11:07 Evolving Views on Plastic Surgery 16:40 Gender Disparities in Medicine 25:44 Friendships, Careers, and Collaboration 28:13 Empowering Personal DecisionsSee omnystudio.com/listener for privacy information.

Dr. Jim Heid is a board-certified family physician and an Associate Certified Coach (ACC) with the International Coaching Federation (ICF). He blends his extensive experience as a family physician with a passion for coaching. He works with individuals in challenging life situations—such as pastors, doctors, business owners, and those in recovery. He has a deep understanding of people and how to serve them in moving forward. Today we discuss: Delivering 1,000 babies Why he decided to add coaching to his CV Combination of doctoring and coaching Clifton Strengths Neuroscience Breathing Jim also talks about “What can I control?” and the importance of really considering the answer to that question when facing a dilemma. Listen now and then share this episode! Find Dr. Jim Heid at https://repurposementllc.com/ Learn more about Jim and find all his links at The Boomer Woman's Podcast: Dr. Jim Heid Want to be a guest on The Boomer Woman's Podcast? Send Agnes a message on PodMatch, here:  Agnes on PodMatch  

In this episode of One in Ten, host Teresa Huizar engages in a thought-provoking conversation with Dr. Jim Hamilton, an associate professor adjunct at Yale School of Medicine, on the topic of medical child abuse. They explore the complexities of why caregivers might fabricate illnesses in their children, the significant discrepancies that pediatricians should look for, and the systemic issues that enable this form of abuse. Dr. Hamilton shares insights from his experience and research, including an innovative study using school nurses to understand the prevalence and detection of medical child abuse. The episode underscores the importance of early intervention, compassionate care, and preventing the escalation of such cases to protect children and support families. Time  Topic 00:00 Introduction to Medical Child Abuse 01:21 Dr. Jim Hamilton's Journey into Medical Deception 04:19 Understanding Medical Child Abuse 06:33 Indicators and Evidence of Medical Child Abuse 09:52 The Role of Healthcare Professionals 12:02 Complexities in Diagnosing Medical Child Abuse 17:22 Systemic Issues and Parental Influence 25:10 Legal Challenges and Case Studies 26:14 The Chilling Reality of Medical Child Abuse 27:16 Prevalence and Study Design Insights 27:52 Understanding Medical Child Abuse: Rare or Not? 31:15 The Role of School Nurses in Identifying Abuse 36:04 Study Findings and Surprising Results 43:00 The Importance of Early Intervention and Compassion 51:40 Final Thoughts and Future Directions ResourcesPrevalence of Suspected Medical Child Abuse in the School Setting: A Study of School Nurses - PubMedSupport the showDid you like this episode? Please leave us a review on Apple Podcasts.

In this episode of the Brain and Life podcast, Dr. Daniel Correa is joined Emmy award-winning broadcaster Mark McEwen. Mark shares his inspiring journey of recovery after suffering a stroke at the age of 52, which led to aphasia. He discusses his broadcasting career, the challenges he faced during recovery, and the importance of hope and resilience. Dr. Correa is then joined by Dr. Rachel Forman, a stroke neurologist and Assistant Professor of Neurology at Yale School of Medicine. Dr. Forman explains stroke risk factors, the importance of awareness, community health initiatives, and access to healthcare to prevent these life-altering events.   Articles Mentioned Stamp Out Stroke Get Smart about Stroke Navigating the Complexities of Stroke   Other Brain & Life Podcast Episodes on These Topics Understanding Stroke with Dr. Laurel Cherian Solving the Stroke with Will Shortz Matt and Kanlaya Cauli on Rebuilding Life After Stroke   We want to hear from you! Have a question or want to hear a topic featured on the Brain & Life Podcast? ·       Record a voicemail at 612-928-6206 ·       Email us at BLpodcast@brainandlife.org   Social Media:   Guest: Dr. Rachel Forman @yaleneurology Hosts: Dr. Daniel Correa @neurodrcorrea; Dr. Katy Peters @KatyPetersMDPhD

Shiur given by Rabbi Bezalel Rudinsky on Dvar Halacha Birchas Hapairos. Shiur recorded in Yeshivas Ohr Reuven, Monsey, NY.

Today, we're diving into one of the most fascinating topics, near-death experiences, and one of the deeply human questions of our time: What happens when we come close to death—and why does it change people forever? Joining me is Dr. Marieta Pehlivanova, Research Assistant Professor of Psychiatry and Neurobehavioral Sciences at the University of Virginia School of Medicine, and a leading researcher at the renowned Division of Perceptual Studies. Today, we explore what near-death experiences are, what people report during them, why these moments are so transformative, and how her research is shaping new approaches to care and support for those who've experienced them. We'll also take a look at how science is evolving to better understand these experiences—and where the field is headed next. Follow Chrissy Newton: Winner of the Canadian Podcast Awards for Best Science Series. YouTube: https://www.youtube.com/channel/UCM32gjHqMnYl_MOHZetC8Eg  Instagram: https://www.instagram.com/beingchrissynewton/  X: https://twitter.com/chrissynewton?lang=en Facebook: https://www.facebook.com/BeingChrissyNewton  Chrissy Newton's Website: https://chrissynewton.com Top Canadian Science Podcast: https://podcasts.feedspot.com/canadian_science_podcasts/       

Dr. Monty Pal and Dr. Jason Westin discuss the federal funding climate for cancer research and the persistent problem of drug shortages, two of the major concerns facing the oncology community in 2026. TRANSCRIPT Dr. Monty Pal: Hello and welcome to the ASCO Daily News Podcast. I am your host, Dr. Monty Pal. I am a medical oncologist and vice chair of academic affairs at the City of Hope Comprehensive Cancer Center in Los Angeles. There are always multiple challenges facing oncologists, and today, we discuss two of them that really stand out for 2026: threats to federal funding for cancer research and the persistent problem of drug shortages. I am thrilled to welcome Dr. Jason Westin, who believes that one way to meet these challenges is to get oncologists more involved in advocacy, and he will share some strategies to help us meet this moment in oncology. Dr. Westin is a professor in the Department of Lymphoma and Myeloma at the University of Texas MD Anderson Cancer Center, but he actually wears a lot of hats within ASCO. He is a member of the Board of Directors and has also previously served as chair of ASCO's Government Relations Committee. And he is also one of the inaugural members of ASCO's Political Action Committee, or PAC. He has testified before Congress about drug shortages and many other issues. Dr. Westin, I am really excited to have you on the podcast today and dive into some of these elements that will really impact our community in 2026. Thanks so much for joining us today. Dr. Jason Westin: Thank you for having me. Dr. Monty Pal: You've had such a range of experience. I already alluded to you testifying before Congress. You've actually run for office before. You wear so many different hats. I'm used to checking my PubMed every other day and seeing a new paper out from you and your group, and you publish in the New England Journal [of Medicine] on practice-setting standards and the diseases that you treat. But you've also done all this work in the domain of advocacy. I can't imagine that balancing that is easy. What has sort of motivated you on the advocacy front? Dr. Jason Westin: Advocacy to me is another way to apply our skills and help more people than just those that you're sitting across from at the time. Clinical research, of course, is a tool to try and take what we know and apply it more broadly to people that you'll never meet. And advocacy, I think, can do the same thing, where you can have a conversation with a lawmaker, you can advocate for a position, and that hopefully will help thousands or maybe even more people down the road who you'd never get to directly interact with. And so, I think it's a force multiplier in the same way that research can be. And so, I think advocacy is a wonderful part of how doctors care for our patients. And it's something that is often difficult to know where to start, but once people get into advocacy, they can see that the power, the rewarding nature of it is attractive, and most people, once they get going, continue with that through the rest of their career. Dr. Monty Pal: So, I'll ask you to expand on that a little bit. We have a lot of our younger ASCO members listening to this podcast, folks that are just starting out their careers in clinical practice or academia. Where does that journey begin? How do you get to the point that you're testifying in front of Congress and taking on these bigger sort of stances for the oncology community? Dr. Jason Westin: Yeah, with anything in medicine and in our careers, you have to start somewhere. And often you start with baby steps before you get in front of a panel of senators or other high-profile engagement opportunities. But often the first setting for junior colleagues to be engaged is doing things – we call them "Hill Days" – but basically being involved in kind of low-stakes meetings where you're with a group of peers, some of whom have done this multiple times before, and can get engaged talking to members of representatives' offices, and doing so in a way where it's a natural conversation that you're telling a story about a patient in your clinic, or that you're telling a personal experience from a policy that impacted your ability to deliver optimal care. It sounds stressful, but once you're doing it, it's not stressful. It's actually kind of fun. And it's a way that you can get comfort and skill with a group of peers who are there and able to help you. And ASCO has a number of ways to do that, both at the federal level, there's the Hill Day where we each April have several hundred ASCO members travel to Capitol Hill. There's also state engagement that can be done, so-called visiting at home, when representatives from the U.S. Congress or from state legislators are back in district. You can meet with your own representatives on behalf of yourself, on behalf of your organization, and advocate for policies in a way that can be beneficial to your patients. But those initial meetings that are in the office often they're low stakes because you could be meeting not with the representative but with their staff. And that staff sometimes is as young or even younger than our junior colleagues. These sometimes can be people in their 20s, but they're often extremely knowledgeable, extremely approachable, and are used to dealing with people who are new to advocacy. But they actually help make decisions within the office. So it's not a waste of time. It's actually a super useful way to engage. So, it's that first step of anything in life. The activation energy is always high to do something new. But I'd encourage people who are listening to this podcast already having some level of interest about it to explore ways that they could engage more. Dr. Monty Pal: You know, I have to tell you, I'm going to riff on what you just said for a second. ASCO couldn't make it any easier, I think, for folks to participate and get involved. So, if you're listening to this and scratching your head and thinking, "Well, where do I begin? How do I actually sign on for that meeting with a local representative?" Go to the ASCO ACT Network website. And I'll actually talk to our producer, Geraldine, to make sure we've got a link to that somewhere associated with this podcast after it's published, Jason, but I actually keep that on my browser and it's super easy. I check in there every now and then and see if there's any new policy or legislation that ASCO, you know, is sort of taking a stance on, and it gives me some fodder for conversation with my local representatives too. I mean, it's just an awesome, awesome vehicle. I'm going to segue right from there right to the issues. So, you and I are both at academic centers. You know, I think this is something that really pervades academia and enters into implications for general clinical practice. There's been this, you know, massive sort of proposal for decreased funding to the NCI and to the NIH and so forth. Tell us what ASCO is doing in that regard, and tell us perhaps how our community can help. Dr. Jason Westin: We live in interesting times, and I think that may be an understatement x 100. But obviously investments in research are things that when you're at an academic center, you see and feel that as part of your daily life. Members of Congress need to be reminded of that because there's a lot of other competing interests out there besides investing in the future through research. And being an elected representative is a hard job. That is something where you have to make difficult choices to support this, and that may mean not supporting that. And there's lots of good things where our tax dollars could be spent. And so, I'm sympathetic to the idea that there's not unlimited resources. However, ASCO has done an excellent job, and ASCO members have led the charge on this, of stating what research does, what is the benefit of research, and therefore why should this matter to elected representatives, to their staff, and to those people that they're elected to serve. And ASCO has led with a targeted campaign to basically have that message be conveyed at every opportunity to elected representatives. And each year on Hill Day, one of the asks that we have is to continue to support research: the NCI, NIH, ARPA-H, these are things that are always in the asks to make sure that there's appropriate funding. But effectively playing offense by saying, "It's not just a number on a sheet of paper, this is what it means to patients. This is what it means to potentially your loved ones in the future if you are in the opposite situation where you're not on the legislative side, but you're in the office receiving a diagnosis or receiving a difficult piece of news." We only have the tools we have now because of research, and each breakthrough has been years in the making and countless hours spent funded through the engine of innovation: clinical research and translational research. And so ASCO continues to beat that drum. You mentioned earlier the ACT Network. Just to bring that back again is a very useful, very easy tool to communicate to your elected representatives. When you sign up on the ASCO ACT website, you get emails periodically, not too much, but periodically get emails of, "This is a way you can engage with your lawmakers to speak up for this." And as you said, Monty, they make it as easy as possible. You click the button, you type in your address so that it figures out who your elected representatives are, and then it will send a letter on your behalf after like five clicks to say, "I want you to support research. I want you to vote for this particular thing which is of interest to ASCO and by definition to members of ASCO." And so the ACT Network is a way that people listening can engage without having to spend hours and significant time, but just a few clicks can send that letter to a representative in Congress. And the question could be: does that matter? Does contacting your senator or your elected representative do anything? If all they're hearing is somebody else making a different argument and they're hearing over and over again from people that want investments in AI or investments in something else besides cancer research, whatever it is, they may think that there's a ground shift that people want dollars to be spent over here as opposed to at the NIH or NCI or in federally funded research. It is important to continue to express the need for federal funding for our research. And so, it really is important for folks to engage. Dr. Monty Pal: 100%. One of the things that I think is not often obvious to a lot of our listeners is where the support for clinical trials comes from. You know, you've obviously run the whole gamut of studies as have I. You know, we have our pharmaceutical company-sponsored studies, which are in a particular bucket. But I would say that there's a very important and critical subset of studies that are actually government funded, right? NCI-funded clinical trials. If you don't mind, just explain to our audience the critical nature of the work that's being done in those types of studies and if you can, maybe compare and contrast the studies that are done in that bucket versus perhaps the pharmaceutical bucket. Dr. Jason Westin: Both are critical, and we're privileged that we have pharma studies that are sponsored and federally funded clinical research. And I think that part of a healthy ecosystem for us to develop new breakthroughs has a need for both. The pharma sponsored studies are done through the lens of trying to get an approval for an agent that's of interest so that the pharma company can then turn around and use that outside of a clinical trial after an FDA approval. And so those studies are often done through the lens of getting over the finish line by showing some superiority over an existing treatment or in a new patient population. But they're done through that lens of kind of the broadest population and sometimes relatively narrow endpoints, but to get the approval so that then the drug can be widely utilized. Clinical trials done through cooperative groups are sometimes done to try and optimize that or to try and look at comparative things that may not be as attractive to pharma studies, not necessarily going for that initial approval, but the fine tuning or the looking at health outcomes or looking at ensuring that we do studies in representative populations that may not be as well identified on the pharma sponsored trials, but basically filling out the gaps in the knowledge that we didn't gain from the initial phase 3 trial that led to the approval. And so both are critical. But if we only do pharma sponsored trials, if we don't fund federally supported research and that dries up, the fear I have, and many others have, is that we're going to be lacking a lot of knowledge about the best ways to use these great new therapies, these new immune therapies, or in my team, we do a lot of clinical trials on CAR T-cell therapies. If we don't have federally funded research to do the important clinical studies, we'll be in the dark about the best ways to use these drugs, and that's going to be a terrible shame. And so we really do need to continue to support federal research. Dr. Monty Pal: Yeah, there are no softball questions on this podcast, but I think everybody would be hard pressed to think that you and I would come on here and say, "Well, no, we don't need as much money for clinical trials and NCI funding" and so forth. But I think a really challenging issue to tackle, and this is something we thought to ask you ahead of the podcast, is what to do about the general climate of, you know, whether it's academic research or clinical practice here that seems to be getting some of our colleagues thinking about moving elsewhere. I've actually talked to a couple of folks who are picking up and moving to Europe for a variety of considerations, other continents, frankly. The U.S. has always been a leader when it comes to oncology research and, one might argue, research in general. Some have the mindset these days that we're losing that footing a little bit. What's your perspective? Are you concerned about some of the trends that you're seeing? What does your crystal ball tell you? Dr. Jason Westin: I am highly concerned about this. I think as you said, the U.S. has been a leader for a long time, but it wasn't always. This is not something that's preordained that the world-leading clinical research and translational research will always be done in the United States. That is something that has been developed as an ecosystem, as an engine for innovation and for job development, new technology development, since World War II. That's something that through intentional investments in research was developed that the best and brightest around the world, if they could choose to go anywhere, you wanted them to come to work at universities and academic places within the United States. And I think, as you said, that's at risk if you begin to dry up the investment in research or if you begin to have less focus on being engaged in research in a way that is forward thinking, not just kind of maintaining what we do now or only looking at having private, for profit sponsored research. But if you don't have the investment in the basic science research and the translational research and the forward-thinking part of it, the fear is that we lose the advantage and that other countries will say, "Thank you very much," and be happy to invest in ways to their advantage. And I think as you mentioned, there are people that are beginning to look elsewhere. I don't think that it's likely that a significant population of researchers in the U.S. who are established and have careers and families – I don't think that we're going to see a mass exodus of folks. I think the real risk to me is that the younger, up-and-coming people in undergraduate or in graduate school or in medical school and are the future superstars, that they could either choose to go into a different field, so they decide not to go into what could be the latest breakthroughs for cancer patients but could be doing something in AI or something in a different field that could be attractive to them because of less uncertainty about funding streams, or they could take that job offer if it's in a different country. And I think that's the concern is it may not be a 2026 problem, but it could be a 2036 or a 2046 problem that we reap what we sow if we don't invest in the future. Dr. Monty Pal: Indeed, indeed. You know, I've had the pleasure of reviewing abstracts for some of our big international meetings, as I'm sure you've done in the past too. I see this trend where, as before, we would see the preponderance of large phase 3 clinical trials and practice setting studies being done here in the U.S., I'm seeing this emergence of China, of other countries outside of the U.S. really taking lead on these things. And it certainly concerns me. If I had to sort of gauge this particular issue, it's at the top of my list in terms of what I'm concerned about. But I also wanted to ask you, Jason, in terms of the issues that are looming over oncology from an advocacy perspective, what else really sort of keeps you up at night? Dr. Jason Westin: I'm quite concerned about the drug shortages. I think that's something that is a surprisingly evergreen problem. This is something that is on its face illogical that we're talking about the greatest engine for research in the world being the United States and the investment that we've made in drug development and the breakthroughs that have happened for patients all around the world, many of them happen in the United States, and yet we don't necessarily have access to drugs from the 1970s or 1980s that are cheap, generic, sterile, injectable drugs. This is the cisplatins and the vincristines and the fludarabine type medications which are not the sexy ones that you see the ads in the magazine or on TV at night. These are the backbone drugs for many of our curative intent regimens for pediatrics and for heme malignancies and many solid tumors. And the fact that that's continuing to be an issue is, in my opinion, a failure to address the root causes, and those are going to require legislative solutions. The root causes here are basically a race to the bottom where the economics to invest in quality manufacturing really haven't been prioritized. And so it's a race to the cheapest price, which often means you undercut your competitor, and when you don't have the money to invest in good manufacturing processes, the factory breaks down, there's no alternative, you go into shortage. And this has been going on for a couple of decades, and I don't think there's an end in sight until we get a serious solution proposed by our elected officials. That is something that bothers me in the ways where we know what we should be doing for our patients, but if we don't have the drugs, we're left to be creative in ways we shouldn't have to do to figure out a plan B when we've got curative intent therapies. And I think that's a real shame.  There's obviously a lot of other things that are concerning related to oncology, but something that I have personally had experience with when I wanted to give a patient a CAR T-cell, and we don't have a supply of fludarabine, which is a trivial drug from decades ago in terms of the technology investments in genetically modified T-cells, to not then have access to a drug that should be pennies on the dollar and available at any time you want it is almost like the Air Force investing in building the latest stealth bomber, but then forgetting to get the jet fuel in a way that they can't use it because they don't have the tools that they need. And so I think that's something that we do need to have comprehensive solutions from our elected officials. Dr. Monty Pal: Brilliantly stated. I like that analogy a lot. Let's get into the weeds for a second. What would that proposal to Congress look like? What are we trying to put in front of them to help alleviate the drug shortages? Dr. Jason Westin: We could spend a couple hours, and I know podcasts usually are not set up to do that. And so I won't go through every part. I will direct you that there have been a couple of recent publications from ASCO specifically detailing solutions, and there was a recent white paper from the Senate Finance Committee that went through some legislative solutions being explored. So Dr. Gralow, ASCO CMO, and I recently had a publication in JCO OP detailing some solutions, more in that white paper from the Senate Finance. And then there's a working group actually going through ASCO's Health Policy Committee putting together a more detailed proposal that will be published probably around the end of 2026. Very briefly, what needs to happen is for government contracts for purchasing these drugs, there needs to be an outlay for quality, meaning that if you have a manufacturing facility that is able to deliver product on time, reliably, you get a bonus in terms of your contract. And that changes the model to prioritize the quality component of manufacturing. Without that, there's no reason to invest in maintaining your machine or upgrading the technology you have in your manufacturing plant. And so you have bottlenecks emerge because these drugs are cheap, and there's not a profit margin. So you get one factory that makes this key drug, and if that factory hasn't had an upgrade in their machines in 20 years, and that machine conks out and it takes 6 months to repair or replacement, that is an opportunity for that drug to go into shortage and causes a mad dash for big hospitals to purchase the drug that's available, leaving disparities to get amplified. It's a nightmare when those things happen, and they happen all the time. There are usually dozens, if not hundreds, of drugs in shortage at any given time. And this has been going on for decades. This is something that we do need large, system-wide fixes and that investment in quality, I think, will be a key part. Dr. Monty Pal: Yeah, brilliantly said. And I'll make sure that we actually include those articles on the tagline for this podcast as well. I'll talk to our producer about that as well.  I'm really glad you mentioned the time in your last comment there because I felt like we just started, but in fact, I think we're right at our close here, Jason, unfortunately. So, I could have gone on for a couple more hours with you. I really want to thank you for these absolutely terrific insights and thank you for all your advocacy on behalf of ASCO and oncologists at large. Dr. Jason Westin: Thank you so much for having me. I have enjoyed it. Dr. Monty Pal: Thanks a lot. And many thanks to our listeners too. You can find more information about ASCO's advocacy agenda and activities at asco.org. Finally, if you value the insights that you heard today on the ASCO Daily News Podcast, please rate, review, and subscribe wherever you get your podcasts. Thanks so much. ASCO Advocacy Resources: Get involved in ASCO's Advocacy efforts: ASCO Advocacy Toolkit Crisis of Cancer Drug Shortages: Understanding the Causes and Proposing Sustainable Solutions, JCO Oncology Practice Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Find out more about today's speakers:     Dr. Monty Pal   @montypal   Dr. Jason Westin @DrJasonWestin   Follow ASCO on social media:      @ASCO on X     ASCO on Bluesky    ASCO on Facebook      ASCO on LinkedIn      Disclosures:     Dr. Monty Pal:    Speakers' Bureau: MJH Life Sciences, IntrisiQ, Peerview   Research Funding (Inst.): Exelixis, Merck, Osel, Genentech, Crispr Therapeutics, Adicet Bio, ArsenalBio, Xencor, Miyarsian Pharmaceutical   Travel, Accommodations, Expenses: Crispr Therapeutics, Ipsen, Exelixis   Dr. Jason Westin: Consulting or Advisory Role: Novartis, Kite/Gilead, Janssen Scientific Affairs, ADC Therapeutics, Bristol-Myers Squibb/Celgene/Juno, AstraZeneca, Genentech/Roche, Abbvie, MorphoSys/Incyte, Seattle Genetics, Abbvie, Chugai Pharma, Regeneron, Nurix, Genmab, Allogene Therapeutics, Lyell Immunopharma Research Funding: Janssen, Novartis, Bristol-Myers Squibb, AstraZeneca, MorphoSys/Incyte, Genentech/Roche, Allogene Therapeutics

Legendary Stanford immunologist Dr. Ed Engleman helped create the foundations of modern cancer treatment. From early breakthroughs in immune-cell training to a brand-new discovery, Engleman explains how the immune system can now be switched on and off like circuitry, with implications for cancer, autoimmune disease, infections and more. He also breaks down his role at Vivo Capital, the global life-sciences venture firm where he evaluates and guides new biotech startups. Engleman describes how Vivo's more conservative, data-driven investment style matches his own approach: digging deep into the science, waiting for real clinical signals, and backing teams that can translate discoveries into actual drugs. A rare conversation with a scientist-founder-investor whose discoveries and companies have reshaped medicine — and who's still chasing the next breakthrough. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this bonus episode of 20-Minute Health Talk, host Sandra Lindsay speaks with filmmaker Richard LaRochelle, who also works with Northwell's community health program. LaRochelle filmed a conversation with four prostate cancer survivors, including former New York Knicks player Allan Houston, with the goal of raising awareness about prostate cancer among the black community. LaRochelle shares his experience in making the short film and what he hopes audiences will learn from the men's experiences.  View The Unspoken Truth: A Dialogue on Prostate Cancer Among Black Men. This bonus episode is Part 4 of this series. Listen to Part 1  Listen to Part 2  Listen to Part 3 About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 21 hospitals, 850 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities.   Facebook –   / northwellhealth   Instagram -   / northwellhealth   X - https://www.x.com/northwellhealth LinkedIn - https://www.linkedin/northwellhealth

Are the Pollutant Levels in Fish High Enough to Be Harmful? The tolerable daily toxin safety limits are based on single chemicals. What if "safe" levels of chemicals in seafood are combined and tested together? Listen to today's episode written by Dr. Michael Greger at @NutritionFacts.org #vegan #plantbased #plantbasedbriefing #fish #fishing #seafood #toxins #environmentaltoxins #toxicbioaccumulation ================== Original post: https://nutritionfacts.org/video/are-the-pollutant-levels-in-fish-high-enough-to-be-harmful  ================== Dr. Michael Greger is a physician, New York Times bestselling author, and internationally recognized speaker on nutrition, food safety, and public health issues. A founding member and Fellow of the American College of Lifestyle Medicine, Dr. Greger is licensed as a general practitioner specializing in clinical nutrition. He is a graduate of the Cornell University School of Agriculture and Tufts University School of Medicine. He founded NUTRITIONFACTS.ORG is a non-profit, non-commercial, science-based public service provided by Dr. Michael Greger, providing free updates on the latest in nutrition research via bite-sized videos. There are more than a thousand videos on nearly every aspect of healthy eating, with new videos and articles uploaded every day.   His latest books —How Not to Die, the How Not to Die Cookbook, and How Not to Diet — became instant New York Times Best Sellers. His two latest books, How to Survive a Pandemic and the How Not to Diet Cookbook were released in 2020.  100% of all proceeds he has ever received from his books, DVDs, and speaking engagements have always and will always be donated to charity. ============================== FOLLOW THE SHOW ON: YouTube: https://www.youtube.com/@plantbasedbriefing     Spotify: https://open.spotify.com/show/2GONW0q2EDJMzqhuwuxdCF?si=2a20c247461d4ad7 Apple Podcasts: https://podcasts.apple.com/us/podcast/plant-based-briefing/id1562925866 Your podcast app of choice: https://pod.link/1562925866 Facebook: https://www.facebook.com/PlantBasedBriefing   LinkedIn: https://www.linkedin.com/company/plant-based-briefing/   Instagram: https://www.instagram.com/plantbasedbriefing/     

Dr. Sarah Clarke, DC, IFMCP, and Dave Hogsed, DOM, AP,  discuss traditional and cultural trends around the consumption of organ meats, and the nutritional value these foods offer. They cover nutrients found various organ meats and how they can either be eaten or taken in supplement form. Dave shares clinical success stories, including his own personal experience, using organ meat glandular therapy. He explains how various organ and glandular meats can support immune function, cardiovascular health, nervous system health, cognitive function, bone health, and more. David Hogsed, DOM, AP, is in full time practice at the Natural Healthcare Professionals clinic in Fort Myers, Florida. His practice specializes in providing effective nutritional support for endocrine, digestion, musculoskeletal, nervous system, and immune system health. David has been a clinical consultant and speaker for Standard Process since 2003. His seminars are best known for simplifying clinical nutrition, herbal medicine, laboratory tests, and patient education. David has taught post-graduate programs through Texas Chiropractic College, Logan Chiropractic College, the University of Miami-Miller School of Medicine, Palmer Chiropractic College, Life University, and Northwestern Chiropractic College. He is a regular speaker for the Florida Chiropractic Association, and Palmer Chiropractic College homecoming. SHOW SUMMARY 2:40 Dave's first personal success story with organ meat glandular therapy 5:15 Clinical results from combining organ meat supplements with herbal and nutritional support 7:06 Organ Meats: the forgotten superfoods – historical consumption around the world 8:50 Traditional Chinese Medicine – consumption of organ would support that organ 9:48 Liver: the most nutrient dense organ meat 12:04 Returning popularity of other traditional foods – raw sauerkraut, bone broths, cod liver oil, and more 12:46 Foods essential for health – "you must take it (as a supplement) or eat it" 14:00 Tips for incorporating liver into your diet 15:03 Key benefits of bone broth and bone extracts 16:53 Animals instinctively know the health benefits of organ meats 18:06 The consumption of heart for cardiovascular health 21:30 Combating the effects of stress with organ meats: liver and adrenal glandular extract 23:30 Studies are now finding additional nutritional benefits in organ meats – mRNA 24:21 Nutritional difference between skeletal muscle meat vs. organ meat 27:24 Studies and historical evidence of health benefits of organ meats 28:17 Liver: the ultimate multivitamin 31:00 Organ meats for immune support – thymus extract 32:40 Historical consumption of brain around the world for cognitive health 34:49 Testicular and ovarian extracts for hormone regulation 35:40 The importance of thymus extracts in young children and with aging populations 36:46 Liver is the king of organ meats

Join us for an honest conversation with Dr. Bradley Block, host of Succeed in Medicine, as we unpack the real-world challenges of being a physician — from career growth and leadership to burnout, work–life balance, and life outside the clinic.

Welcome to another wide-ranging "Random Show" episode that I recorded with my close friend Kevin Rose (digg.com)!This episode is brought to you by:Qlosi prescription eye drop used to treat age-related blurry near vision (presbyopia) in adults: https://Qlosi.com/TimDavid Protein Bars with 28g of protein, 150 calories, and 0g of sugar: https://davidprotein.com/Tim (Buy 4 cartons, get the 5th free.)Eight Sleep Pod Cover 5 sleeping solution for dynamic cooling and heating: EightSleep.com/Tim (use code TIM to get $400 off your very own Pod 5 Ultra)Coyote the card game​, which I co-created with Exploding Kittens: https://coyotegame.com*For show notes and past guests on The Tim Ferriss Show, please visit tim.blog/podcast.For deals from sponsors of The Tim Ferriss Show, please visit tim.blog/podcast-sponsorsSign up for Tim's email newsletter (5-Bullet Friday) at tim.blog/friday.For transcripts of episodes, go to tim.blog/transcripts.Discover Tim's books: tim.blog/books.Follow Tim:Twitter: twitter.com/tferriss Instagram: instagram.com/timferrissYouTube: youtube.com/timferrissFacebook: facebook.com/timferriss LinkedIn: linkedin.com/in/timferrissSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Join My Newsletter For My Book & Updates on my Anxiety Freedom Course: https://learntruehealth.com/free Get The Free Course & Learn More: https://chehomeopathy.com BOOK: Homeopathy at Home: Everyday Treatments for Common Complaints https://amzn.to/3KEoNdj learntruehealth.com/structuredwater, to check out the science, studies, and new devices. Remember your coupon code LTH during checkout!

How can one tree be said to bless, protect, seduce… and curse?In this episode, I'm joined by herbalist and writer Ruthie Kølle for a deep dive into one of my all-time favorite plants: hawthorn (Crataegus spp.). Together, we explore hawthorn's rich folklore, its potent heart-centered gifts, and the magic woven into its thorns, blossoms, and berries. Drawing from her Celtic heritage, Ruthie shares how hawthorn is not just a medicine, but a living bridge to old-world traditions and ancestral ways of healing.Ruthie brought us her recipe for Anam Cara Heart Opening Cordial, a delightful blend of hawthorn and other rose-family plants. I love how this recipe can be so easily adapted to reflect the region you live in! You can download a beautifully illustrated recipe card here. By the end of this episode, you'll know:► Three different body systems that benefit from hawthorn's gifts► What makes hawthorn so nourishing and protective, both for the ecosystem and for the human body► Why most people could benefit from working with hawthorn on a daily basis► Five different ways to include hawthorn in food► Why hawthorn is called the "trysting tree" in Irish lore—and what that has to do with the putrid smell of its flowers► and so much more…For those of you who don't know her, Ruthie Kølle lives in a cabin situated on the northern hem of her family's 9th generation farm, which occupies unceded Lenape land. She is deeply rooted to her place there and has apprenticed herself to reconnecting to her own Celtic ancestral ways, weaving them into the stories of the land where she is currently planted. It's her passion to reconnect with and integrate these traditional and ritual methods of healing into our modern lives.Ruthie has been studying folk and clinical herbalism since 2012, has been practicing intuitive bodywork since 2005, and creating ceramic art for 30 years.This conversation is so full of wonder, story, and heartfelt herbal wisdom. If you've ever felt drawn to hawthorn—or are curious why so many people fall in love with this tree—you won't want to miss this episode!----Get full show notes, transcript, and more information at: herbswithrosaleepodcast.comWould you prefer watching this episode? If so, click here for the video.You can find Ruthie at MotherHylde.com.For more behind-the-scenes of this podcast, follow @rosaleedelaforet on Instagram!Working successfully with herbs requires three essential skills. Get introduced to them by taking my free herbal jumpstart course when you sign up for my newsletter.If you enjoy the Herbs with Rosalee podcast, we could use your support! Please consider leaving a 5-star rating and review and sharing the show with someone who needs to hear it!On the podcast, we explore the many ways plants heal, as food, as medicine, and through nature connection. Each week, I focus on a single seasonal plant and share trusted herbal knowledge so that you can get the best results when using herbs for your health.Learn more about Herbs with Rosalee at herbswithrosalee.com.----Rosalee is an herbalist and author of...

The Counter Momentum of Spin, with Dr. Franco Musio – Mass media and technology have infiltrated all sectors of our lives, including exercise: wearable technology (smartwatches, fitness trackers, and rings monitor our physiological parameters, giving real-time feedback); smart equipment and apps (AI-powered apps for personalized workouts and data analysis); virtual and...

Dr. Marc Siegel, Clinical Professor of Medicine & Fox News Contributor, joins Sid to touch upon his book The Miracles Among Us: How God's Grace Plays a Role in Healing. The conversation spans various topics, including recent sports events, personal health anecdotes, and the interplay between faith and medical advancements. Siegel emphasizes the importance of integrating spirituality with technological advancements in medicine. He recounts stories from his book about miraculous recoveries and the power of prayer in healing, underscoring the role of faith and community support in medical outcomes. Learn more about your ad choices. Visit megaphone.fm/adchoices

(December 03, 2025) Costco is poking the Trump Bear. Cash strapped shoppers opt for essentials and buy-now-pay-later services. Dr. Jim Keany, Chief Medical Officer at Dignity Health St. Mary Medical Center in Long Beach, joins The Bill Handel Show for 'Medical News'! Dr. Keany talks with Bill about tattoo ink moving through the body, killing immune cells and weakening vaccine response, and men with ‘beer bellies’ may face serious heart damage even if they aren’t overweight.See omnystudio.com/listener for privacy information.

Vascular and inflammatory diseases after COVID-19 infection and vaccination in children and young people in England: a retrospective, population-based cohort study using linked electronic health recordsComparison of an Initial Risk-Based Testing Strategy vs Usual Testing in Stable Symptomatic Patients With Suspected Coronary Artery Disease: The PRECISE Randomized Clinical Trial This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe

Send us a textIn this episode, Dr. Andrew Beverstock discusses his research on urinary sodium and its relationship with growth in preterm neonates. He shares insights into the importance of sodium for neonatal growth, the methodology of his study, and the unexpected results that challenge existing literature. The conversation also touches on his diverse medical training, mentorship experiences, and his involvement in medical education and point-of-care ultrasound (POCUS). Dr. Beverstock emphasizes the significance of careful population selection in research and outlines his future research directions. Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

This week, we look at new trials on glucocorticoids for pneumonia in Africa, shunting for normal-pressure hydrocephalus, and pegcetacoplan for two rare kidney diseases. We review updated vaccine evidence for Covid-19, RSV, and influenza, and present a case of respiratory decline and muscle weakness. Perspectives explore health care incentives, U.S. global health strategy, and bringing AI-enabled care to rural America.

The Revolutionary Role of the Vagus Nerve in Bioelectronic Medicine: Dr. Kevin J. Tracey, president and CEO at the Feinstein Institutes for Medical Research and author of "The Great Nerve: The New Science of the Vagus Nerve and How to Harness Its Healing Reflexes,” details the historical context and recent advancements in harnessing the power of the vagus nerve to control inflammation without causing immunosuppression. The conversation explores the journey from early experimental stages to the recent FDA approval for treating rheumatoid arthritis through vagus nerve stimulation (VNS) devices. He also delves into the potential applications of VNS in treating other inflammatory conditions, mood disorders, and the science behind non-invasive lifestyle techniques and commercially available devices. The episode provides valuable insights into the future of bioelectronic medicine and its potential to revolutionize medical treatments.

Dr. Hoffman continues his conversation with Dr. Kevin J. Tracey, president and CEO at the Feinstein Institutes for Medical Research and author of "The Great Nerve: The New Science of the Vagus Nerve and How to Harness Its Healing Reflexes.”

Welcome to Resiliency Radio with Dr. Jill Carnahan, where today's powerful episode explores what it truly means to reclaim medicine through aligned leadership, personal transformation, and a return to root-cause, patient-centered care. Dr. Jill is joined by the inspiring Lundquist brothers - Dr. Erik Lundquist and Dr. Davin Lundquist—two nationally respected leaders in integrative, functional, and holistic medicine. In this episode, we dive deep into the emotional and professional challenges facing today's healthcare professionals, including burnout, chronic stress, and system-driven limitations that leave both clinicians and patients overwhelmed. Together, the Lundquist brothers break down what real leadership looks like in medicine—revealing the difference between simply managing and truly inspiring transformation in others. You'll learn how personal growth begins with small, courageous steps; how functional and holistic medicine empowers individuals to reclaim their health; and how hope, mindset, and aligned leadership can reshape the future of healthcare. Whether you're a clinician seeking renewed purpose or a patient longing for a more compassionate, whole-person medical approach, this conversation offers deep wisdom, practical insight, and a renewed sense of possibility.

Robert Huckman is a professor of business administration at Harvard Business School and a research associate at the National Bureau of Economic Research. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D.M. Cutler and R.S. Huckman. Has Corporatization Met Its Match? The Challenge of Making Money by Keeping People Healthy. N Engl J Med 2025;393:2177-2180.

The Stowers Institute in Kansas City, which focuses on disease and treatment methods, added its first artificial intelligence fellow as a part of its AI initiative. This group of researchers is training AI to analyze research data and find the patterns and regulations that make cells function.

Join Liz Cruz M.D. and Tina Nunziato, Certified Holistic Nutrition Consultant, as they discuss Artificial Intelligence in medicine with their podcasting guests, Naturopathic Doctor, Dr. Krystal Tellier and her husband and Business Manager, Paul Tellier.  Learn the pros and cons of AI in medicine today and what patients need to know regarding using AI for medical advice and treatment plans.  Do not refer to AI for your medical concerns until you've listened to this podcast.  If you'd like to connect with Dr. Tellier, check out her website at https://healthforlifend.com/ or call 602-368-9211.Watch us on YouTube:  https://youtu.be/_xGn3UE2p4EDr. Cruz is a Board Certified Gastroenterologist who practices in Phoenix, AZ. Along with her wife Tina Nunziato, a Certified Holistic Nutritionist, they have helped tens of thousands of individuals get well from a more holistic standpoint. They focus on issues such as constipation, diarrhea, acid reflux, heartburn, gas, bloating, food sensitivities, IBS, Crohn's disease, and diverticulitis in addition to a person's general overall health. They do this by teaching about real food, water, digestive enzymes, probiotics, detox, greens, electrolytes, food sensitivity testing, and so much more. If you're struggling with finding the answers to your issues, tired of not feeling well, and sick of taking over the counter and prescription medicines, schedule a FREE 30 minute phone consult at www.drlizcruz.com.For more information visit www.digestthispodcast.com or www.drlizcruz.com. Enjoy the show! Dr. Liz Cruz and Tina Nunziato, CHNC

Shiur given by Rabbi Bezalel Rudinsky on Dvar Halacha Birchas Hapairos. Shiur recorded in Yeshivas Ohr Reuven, Monsey, NY.

In this episode, Gregory J. Tiesi, MD, FACS, FSSO, hosted a discussion about innovations in regional cancer therapies. Dr Tiesi is the medical director of Hepatobiliary Surgery at the Hackensack Meridian Jersey Shore University Medical Center in Toms River and Brick, New Jersey. He was joined by: Anthony Scholer, MD, FACS, FSSO, a surgical oncologist specializing in hepatobiliary surgery, at Hackensack Meridian Medical Group and Jersey Shore University Medical Center in Neptune, New Jersey Benjamin Jon Golas, MD, FACS, regional chief of Surgical Oncology for Hackensack Meridian Health's Central Region, surgical director of Oncology Services at Jersey Shore University Medical Center, vice chair of Surgery at Jersey Shore University Medical Center Cancer Surgery, and an associate professor of surgery at the Hackensack Meridian School of Medicine in Neptune and Edison, New Jersey Eric Pletcher, MD, a surgeon specializing in Complex General Surgical Oncology at Hackensack Meridian JFK University Medical Center in Edison Drs Tiesi, Scholer, Golas, and Pletcher chatted about the use of pressurized intraperitoneal aerosolized chemotherapy (PIPAC), a minimally invasive regional cancer therapy designed for patients with peritoneal metastases or primary peritoneal cancers. The experts explained that this laparoscopic approach overcomes several limitations of traditional systemic treatments by delivering aerosolized chemotherapy in fine droplets under high pressure into the peritoneal cavity. This process ensures uniform drug distribution and enhanced tissue penetration, allowing for efficacy with lower systemic drug concentrations, they noted.  PIPAC candidates typically present with unresectable or recurrent disease, or symptomatic malignant ascites, and should have an ECOG performance status between 0 and 2, they elaborated. The procedure, which is repeatable every 4 to 6 weeks, includes diagnostic laparoscopy, quantification of the peritoneal carcinomatosis index, and serial biopsies to assess treatment response. They emphasized that PIPAC has a favorable safety profile, with low 30-day mortality rates and minimal grade 3/4 adverse effects reported in clinical trials. Additionally, they stated that clinical data indicate high pathologic response rates and the potential for disease downstaging, enabling some patients who were initially deemed unresectable to become eligible for subsequent cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Of note, the experts reported that PIPAC is designed to be integrated seamlessly with concurrent systemic therapy.

Send us a textPhone lines are jammed. Staff are overwhelmed. Patients wait, hang up, or fall through the cracks entirely. Meanwhile, the pressure to improve access keeps climbing.In this Executive Feature, Chetan Reddy, Founder and CEO of Confido Health,  joins host, David E. Williams to discuss why patient access is breaking down, how AI voice agents can resolve routine calls instantly, and what it takes for practices to improve patient experience without adding staff.

In this episode of 20 Minute Health Talk, host Sandra Lindsay delves into the emotional journey of prostate cancer from the unique perspectives of supportive partners. Joining her are two remarkable women, Mary Hillery and Tamara Houston, who share their experiences as caregivers alongside their husbands, prostate cancer survivors Tony Hillery and former New York Knicks player Allan Houston. Mary Hillery, a human resources expert, offers insights on resilience and caregiving. Tamara Houston, an educator and advocate for youth empowerment, speaks on the power of faith and familial support in challenging times.  This is Part 3 of this series. Listen to Part 1  Listen to Part 2  About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 21 hospitals, 850 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities.   Facebook –   / northwellhealth   Instagram -   / northwellhealth   X - https://www.x.com/northwellhealth LinkedIn - https://www.linkedin/northwellhealth

Can your cholesterol drop more than 150 points in just 15 days without medication?   Dr. Ted Barnett joins Chuck Carroll at the International Conference on Nutrition and Medicine to reveal the stunning results he's seeing with patients who adopt a whole food plant-based diet.   Inside Lifestyle Medicine Grand Rounds, Dr. Barnett has witnessed cholesterol levels fall by 150–200 points in two weeks, average drops of 64 points, and dramatic improvements in blood sugar, inflammation, and energy — often outperforming the results of statins.   This episode dives deep into why lifestyle changes can be more powerful than prescriptions, what's holding back the medical system from using these tools, and how simple foods like arugula, broccoli, sweet potatoes, mushrooms, and black-eyed peas can transform your health quickly.   What You'll Learn:  - How patients are lowering cholesterol 150+ points naturally - Why whole food plant-based diets outperform many medications - The 15-Day Jumpstart program and its life-changing results - Why the medical system overlooks lifestyle solutions - The top foods Dr. Barnett "prescribes" to every patient - How doctors collaborate in Lifestyle Medicine Grand Rounds - How you can experience similar results at home   Please support PCRM and The Exam Room Podcast on Giving Tuesday. Your gift will be matched dollar-for-dollar to fuel the content you love, like this podcast, while keeping all of PCRM's lifesaving work moving full steam ahead. Please donate today: https://pcrm.org/examroommatch